We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Actions that trial sponsors should consider to build resilience into clinical trial design
Video series explaining the main changes introduced by the Windsor Framework on the supply of medicines in Northern Ireland.
Industry webinars on the main changes introduced by the Windsor Framework on the supply of medicines in Northern Ireland.
How to test and report levels of nicotine uptake when submitting a notification of intent to market e-cigarette and vape products in Great Britain.
Due diligence for suppliers of e-cigarettes and e-liquids.
Information and advice on submitting a dermatological product to the Advisory Committee for Borderline Substances (ACBS).
Outlines the aim, scope and definitions of the medical technology innovation classification framework.
The Medicines and Healthcare products Regulatory Agency regulates medicines, medical devices and blood components for transfusion in the UK.
Interventions that can be made by pharmacy teams, to improve quality of life for older people.
Confirmation of the regulation 251 of the Human Medicines Regulation following the Brexit transition.
Advice for manufacturers, members of the public and professional users of software or apps being used during the COVID-19 pandemic.
Information for pharmaceutical wholesalers explaining the main changes the Windsor Framework introduces to the packaging for all medicines licensed in the UK, effective from 1 January 2025.
Sets out the payment due from members of the voluntary scheme for branded medicines pricing and access in 2023.
Sets out the payment due from members of the voluntary scheme for branded medicines pricing and access in 2022.
VDEC’s Discovery and surveillance capabilities provide unique services across a spectrum of molecular immunology platforms.
Qualified Persons (QPs) should follow the below guidance on the flexible approaches we are taking for medicines imported from third countries.
Information for retailers from Great Britain supplying medical devices to Northern Ireland.
VDEC works with global leaders from all sectors to develop and deliver the vaccine and therapeutic products we need to protect us from infectious diseases.
Sets out the process for pharmaceutical companies to appeal against decisions made by the Secretary of State for Health and Social Care.
Access Consortium Statement on Good Manufacturing Practice (GMP) Inspections Reliance and Recognition
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).